A summary of the key achievements between July and September 2015 is provided below:
Scale-up of integrated HIV services had reached the following number of sites:
724 static (579 within and 145 outside of health facilities) and 188 outreach HTC sites
717 (static) ART sites
619 PMTCT sites (Option B+, all included in ART sites above)
663 Pre-ART sites
650 sites with HIV-exposed child follow-up
625,803 persons were tested for HIV and received their results; 190,051 (30%) accessed HTC for the
first time; 435,752 (70%) were repeat testers and 13,093 (3%) of these received confirmatory
testing (after having tested positive in the past). This is equivalent to 51% confirmatory testing
coverage among 25,737 patients initiating ART this quarter. 34,966 (6%) clients received a positive
result for the first time.
16,645 (94%) of 17,773 blood units collected were screened for (at least) HIV, hepatitis B and
142,701 (91%) of 156,851 women at ANC had their HIV status ascertained; 11,113 (8%) of these
were HIV positive. 129,887 (97%) of 133,931 women at maternity had their HIV status ascertained
9,868 (8%) of these were HIV positive.
25,737 patients started ART this quarter.
585,660 patients were alive and on ART by end of September 2015. This means that 59% of the
estimated 1 million HIV positive population was on ART. 1 Estimated ART coverage among people in
need for treatment1 was 50% (50,533 / 101,000) for children (<15 years) and 68% (531,990 /
779,000) for adults.
78% of adults and 79% of children were retained alive on ART at 12 months after initiation. Actual
retention rates are thought to be about 10% higher due to misclassification of ‘silent transfers’ as
defaulters in clinic-based survival/retention analysis. (see section 15.4)
510,798 (93%) of 574,610 patients on first line adult ART were on regimen 5A (TDF/3TC/EFV).
11,823 2 (79%) of an estimated 14,926 HIV infected pregnant women in Malawi were on ART this
quarter. 7,031 (59%) of these were already on ART when getting pregnant and 4,792 (41%) started
ART during pregnancy/delivery.
An additional 1,555 breastfeeding women started ART due to Option B+ (in WHO stage 1/2)
78%, 71%, 67% and 66% of women started under Option B+ were retained on ART at 6, 12, 24 and
36 months after initiation, respectively.
9,019 (7%) of infants discharged alive from maternity were known to be HIV exposed, 8,414 (93%)
of these received ARV prophylaxis (nevirapine). 7,558 (84%) were enrolled in exposed child followup
before age 2 months.
A total of 11,357 HIV exposed children and 6,929 pre-ART patients were enrolled for follow-up in
HIV Care Clinics (HCC) during this quarter.